Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Clinical trial NCT01813721 · COMPLETED

Trial details

NCT number: NCT01813721
Sponsor: Amgen
Status: COMPLETED
Study type: OBSERVATIONAL

Chemotherapy-induced Febrile Neutropenia

Start date: 2012-12-01
Primary completion: 2013-12-01
Enrollment: 1007

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.